Holen Sie sich die Stockscreener-App
2.20
0.45%
-0.010
Handel nachbörslich:
2.23
0.03
+1.36%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IOVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$2.21
Offen:
$2.2
24-Stunden-Volumen:
7.40M
Relative Volume:
0.49
Marktkapitalisierung:
$796.08M
Einnahmen:
$241.53M
Nettoeinkommen (Verlust:
$-389.92M
KGV:
-1.7886
EPS:
-1.23
Netto-Cashflow:
$-323.54M
1W Leistung:
-1.35%
1M Leistung:
-22.26%
6M Leistung:
-43.88%
1J Leistung:
-79.01%
1-Tages-Spanne:
$2.11
$2.21
1-Wochen-Bereich:
$2.11
$2.35
52-Wochen-Spanne:
$1.6385
$12.51
Iovance Biotherapeutics Inc Stock (IOVA) Company Profile
Firmenname
Iovance Biotherapeutics Inc
Sektor
Branche
Telefon
(650) 260-7120
Adresse
825 INDUSTRIAL ROAD, SAN CARLOS
Vergleichen Sie IOVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IOVA
Iovance Biotherapeutics Inc
|
2.20 | 792.46M | 241.53M | -389.92M | -323.54M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Herabstufung | Goldman | Neutral → Sell |
| 2025-05-16 | Herabstufung | UBS | Buy → Neutral |
| 2025-05-12 | Herabstufung | Truist | Buy → Hold |
| 2025-05-09 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-07-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-11-20 | Eingeleitet | Goldman | Buy |
| 2023-09-18 | Bestätigt | Barclays | Overweight |
| 2023-05-30 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-03-27 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2023-01-27 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-12-09 | Herabstufung | Goldman | Buy → Neutral |
| 2022-10-31 | Eingeleitet | Guggenheim | Neutral |
| 2022-08-18 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2022-01-28 | Hochstufung | Stifel | Hold → Buy |
| 2021-12-07 | Fortgesetzt | Cowen | Outperform |
| 2021-06-10 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2021-05-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-05-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-05-19 | Herabstufung | Stifel | Buy → Hold |
| 2021-05-03 | Eingeleitet | Truist | Buy |
| 2021-04-16 | Eingeleitet | Goldman | Buy |
| 2021-03-08 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-12-15 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-10-06 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-04-22 | Eingeleitet | Mizuho | Buy |
| 2020-03-04 | Eingeleitet | Barclays | Overweight |
| 2020-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-02-26 | Bestätigt | Oppenheimer | Outperform |
| 2019-12-18 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-10-01 | Eingeleitet | Stifel | Buy |
| 2019-04-29 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-02-28 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-02-07 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-12-31 | Fortgesetzt | B. Riley FBR | Buy |
| 2018-07-06 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-04-10 | Hochstufung | B. Riley FBR, Inc. | Neutral → Buy |
| 2018-03-13 | Bestätigt | B. Riley FBR, Inc. | Neutral |
| 2018-02-23 | Herabstufung | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-01-25 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-01 | Bestätigt | B. Riley FBR, Inc. | Buy |
Alle ansehen
Iovance Biotherapeutics Inc Aktie (IOVA) Neueste Nachrichten
Artisan Small Cap Fund Exited Its Stake in Iovance Biotherapeutics (IOVA) Due to Operational Challenges - MSN
Short Term Charts Align With Long Term Uptrend in Iovance Biotherapeutics Inc.July 2025 Recap & Free Weekly Watchlist of Top Performers - beatles.ru
Risk adjusted return profile for Iovance Biotherapeutics Inc. analyzedQuarterly Market Summary & Daily Oversold Stock Bounce Ideas - Newser
What institutional flow reveals about Iovance Biotherapeutics Inc.July 2025 Big Picture & Safe Entry Point Identification - Newser
Iovance Biotherapeutics shares rise 1.32% premarket after Immunome's presentation at H.C. Wainwright conference. - AInvest
Can machine learning forecast Iovance Biotherapeutics Inc. recovery2025 Breakouts & Breakdowns & Free Long-Term Investment Growth Plans - Newser
How to read the order book for Iovance Biotherapeutics Inc.Portfolio Risk Summary & Safe Capital Allocation Plans - Newser
Multi asset correlation models including Iovance Biotherapeutics Inc.July 2025 Trends & Momentum Based Trading Ideas - Newser
Is this a good reentry point in Iovance Biotherapeutics Inc.2025 Short Interest & Daily Technical Stock Forecast Reports - Newser
How to use a screener to detect Iovance Biotherapeutics Inc. breakoutsWeekly Profit Analysis & High Conviction Buy Zone Alerts - Newser
Using Bollinger Bands to evaluate Iovance Biotherapeutics Inc.Portfolio Gains Report & Risk Controlled Daily Plans - Newser
How to recover losses in Iovance Biotherapeutics Inc. stockMarket Volume Summary & Safe Capital Growth Trade Ideas - Newser
Custom watchlist performance reports with Iovance Biotherapeutics Inc.Weekly Trend Report & Intraday High Probability Setup Alerts - Newser
Chart overlay techniques for tracking Iovance Biotherapeutics Inc.Earnings Recap Summary & High Conviction Buy Zone Picks - Newser
Is Iovance Biotherapeutics Inc. stock bottoming outDay Trade & Stepwise Swing Trade Plans - Newser
Does Iovance Biotherapeutics Inc. qualify in momentum factor screening2025 EndofYear Setup & Verified Chart Pattern Signals - Newser
Valuation Update: Is Iovance Biotherapeutics Inc. benefiting from interest rate changesMarket Performance Summary & Risk Controlled Stock Pick Alerts - khodrobank.com
What to expect from Iovance Biotherapeutics Inc. in the next 30 daysMarket Risk Report & Long-Term Growth Stock Strategies - Newser
Published on: 2025-09-01 23:03:51 - Newser
Real time social sentiment graph for Iovance Biotherapeutics Inc.Market Rally & Safe Entry Trade Reports - Newser
Building trade automation scripts for Iovance Biotherapeutics Inc.2025 Trading Recap & Daily Profit Maximizing Tips - Newser
Will Iovance Biotherapeutics Inc. bounce back from current supportMarket Performance Report & Fast Moving Stock Watchlists - Newser
Chart based analysis of Iovance Biotherapeutics Inc. trendsMarket Performance Recap & AI Driven Stock Price Forecasts - Newser
Is Iovance Biotherapeutics Inc. forming a bullish divergenceJuly 2025 Sentiment & Weekly Stock Breakout Alerts - kpenews.com
Is Iovance Biotherapeutics Inc. benefiting from interest rate changesDip Buying & Stepwise Entry and Exit Trade Signals - khodrobank.com
Key resistance and support levels for Iovance Biotherapeutics Inc.Market Trend Review & Safe Capital Preservation Plans - Newser
Detecting support and resistance levels for Iovance Biotherapeutics Inc.Earnings Growth Report & Verified Technical Signals - Newser
Intraday pattern recognizer results for Iovance Biotherapeutics Inc.Market Performance Recap & Stock Portfolio Risk Management - Newser
Will Iovance Biotherapeutics Inc. benefit from macro trendsEarnings Recap Summary & Reliable Entry Point Trade Alerts - Newser
Can momentum traders help lift Iovance Biotherapeutics Inc.Gap Up & Breakout Confirmation Trade Signals - Newser
Will Iovance Biotherapeutics Inc. continue its uptrendPortfolio Return Report & Fast Gain Stock Trading Tips - Newser
Iovance Biotherapeutics Inc. stock daily chart insightsMarket Sentiment Summary & Fast Exit/Entry Strategy Plans - Newser
Price momentum metrics for Iovance Biotherapeutics Inc. explainedAnalyst Upgrade & Free High Accuracy Swing Entry Alerts - Newser
Tools to monitor Iovance Biotherapeutics Inc. recovery probabilityJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - Newser
Published on: 2025-08-31 01:35:26 - Newser
Can Iovance Biotherapeutics Inc. maintain sales growthMarket Activity Report & Verified Trade Idea Suggestions - sundaytimes.kr
Can Iovance Biotherapeutics Inc. Rally Enough to Break Even getLinesFromResByArray error: size == 0 - kangso.co.kr
How to build a custom watchlist for Iovance Biotherapeutics Inc.Sell Signal & Stock Market Timing Techniques - Newser
Finanzdaten der Iovance Biotherapeutics Inc-Aktie (IOVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Iovance Biotherapeutics Inc-Aktie (IOVA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Puri Raj K. | Chief Regulatory Officer |
Jun 02 '25 |
Option Exercise |
0.00 |
5,469 |
0 |
212,321 |
| Vogt Frederick G | Interim CEO & General Counsel |
Jun 02 '25 |
Option Exercise |
0.00 |
52,085 |
0 |
426,731 |
| GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer |
Jun 02 '25 |
Option Exercise |
0.00 |
12,695 |
0 |
105,608 |
| BILINSKY IGOR | Chief Operating Officer |
Jun 02 '25 |
Option Exercise |
0.00 |
12,305 |
0 |
99,883 |
| Bellemin Jean-Marc | Chief Financial Officer |
Jun 02 '25 |
Option Exercise |
0.00 |
8,789 |
0 |
64,993 |
| Puri Raj K. | Chief Regulatory Officer |
May 23 '25 |
Buy |
1.74 |
5,600 |
9,743 |
206,852 |
| Vogt Frederick G | Interim CEO & General Counsel |
May 14 '25 |
Buy |
1.69 |
25,000 |
42,250 |
374,646 |
| Puri Raj K. | Chief Regulatory Officer |
Mar 14 '25 |
Option Exercise |
0.00 |
8,334 |
0 |
203,761 |
| Bellemin Jean-Marc | Chief Financial Officer |
Mar 03 '25 |
Option Exercise |
0.00 |
58,590 |
0 |
87,938 |
| BILINSKY IGOR | Chief Operating Officer |
Mar 03 '25 |
Option Exercise |
0.00 |
62,106 |
0 |
120,880 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):